Trials / Completed
CompletedNCT02335346
An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)
An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Osteoarthritis and Knee Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 40 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of duloxetine in participants with osteoarthritis and knee pain. The study will last for 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered orally |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-01-09
- Last updated
- 2019-09-18
- Results posted
- 2017-11-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02335346. Inclusion in this directory is not an endorsement.